Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - docusate sodium,sennosides -

United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam 0.25 mg - xanax is indicated for the: xanax is contraindicated in patients: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including xanax, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/research/pregnancyregistry/. neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.8) and clinical considerations)] . available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see data ). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adve

United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam 0.5 mg - xanax xr is indicated for the treatment of panic disorder with or without agoraphobia, in adults. xanax xr is contraindicated in patients: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including xanax xr, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/. neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.8), and clinical considerations)] . available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see data ). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pre

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - paracetamol, quantity: 555.55 mg (equivalent: crospovidone, qty 2.78 mg; equivalent: stearic acid, qty 5.55 mg; equivalent: pregelatinised maize starch, qty 16.67 mg; equivalent: maize starch, qty 19.44 mg; equivalent: povidone, qty 11.11 mg); chlorphenamine maleate, quantity: 2 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; povidone; crospovidone; stearic acid - fast effective, temporary relief from the following symptoms of colds and flu: headache, body aches & pains, sneezing, watery & itchy eyes, runny nose. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - loratadine -

United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - halcion is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. halcion is contraindicated in: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including halcion, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/ risk summary neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.10) and ]. available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see ) . the background risk of major birth defects and miscarriage for the indicated population is unknown. all pr

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - cetirizine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - fluconazole -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - codeine phosphate hemihydrate,ibuprofen -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - codeine phosphate hemihydrate,ibuprofen -